Tanel Traks
Tartu, Estonia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Adherence to Psoriasis Remote Monitoring and Its Associations With Demographic, Clinical, and Health Care Use Characteristics: Multicenter Observational Study.
Journal: JMIR formative research
Published: December 17, 2025
Evaluating the impact of communicating high polygenic risk for coronary artery disease on the health behaviour of young overweight adults: a pragmatic randomised controlled trial.
Journal: Scientific reports
Published: October 08, 2025
Genetic liability to psoriasis predicts severe disease outcomes.
Journal: Genome medicine
Published: July 07, 2024
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.
Journal: medRxiv : the preprint server for health sciences
Published: October 24, 2023
Non-Invasive Assessment of Skin Surface Proteins of Psoriasis Vulgaris Patients in Response to Biological Therapy.
Journal: International journal of molecular sciences
Published: October 15, 2023
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.
Journal: Nature communications
Published: October 04, 2023
High-throughput proteomic analysis of chronic inflammatory skin diseases: Psoriasis and atopic dermatitis.
Journal: Experimental dermatology
Published: August 14, 2023
Polymorphisms in corticotrophin-releasing hormone-proopiomalanocortin (CRH-POMC) system genes: Neuroimmune contributions to psoriasis disease.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 07, 2023
Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus.
Journal: Metabolites
Published: December 06, 2022
The Expression Pattern of Genes Related to Melanogenesis and Endogenous Opioids in Psoriasis.
Journal: International journal of molecular sciences
Published: October 19, 2021
Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene: results from a multicentre study of four European psoriasis cohorts.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 27, 2019
Last Updated: 09/26/2026